Results
|
5561.
|
EPIC: phase III trial of cetuximab plus irinotecan after fluoropyrimidine and oxaliplatin failure in patients with metastatic colorectal cancer. [electronic resource] by
- Sobrero, Alberto F
- Maurel, Joan
- Fehrenbacher, Louis
- Scheithauer, Werner
- Abubakr, Yousif A
- Lutz, Manfred P
- Vega-Villegas, M Eugenia
- Eng, Cathy
- Steinhauer, Ernst U
- Prausova, Jana
- Lenz, Heinz-Josef
- Borg, Christophe
- Middleton, Gary
- Kröning, Hendrik
- Luppi, Gabriele
- Kisker, Oliver
- Zubel, Angela
- Langer, Christiane
- Kopit, Justin
- Burris, Howard A
Producer: 20080527
In:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 26
Availability: No items available.
|
|
5562.
|
|
|
5563.
|
Is resection of colorectal liver metastases after a second-line chemotherapy regimen justified? [electronic resource] by
- Brouquet, Antoine
- Overman, Michael J
- Kopetz, Scott
- Maru, Dipen M
- Loyer, Evelyne M
- Andreou, Andreas
- Cooper, Amanda
- Curley, Steven A
- Garrett, Christopher R
- Abdalla, Eddie K
- Vauthey, Jean-Nicolas
Producer: 20111115
In:
Cancer vol. 117
Availability: No items available.
|
|
5564.
|
|
|
5565.
|
Phase II study of irinotecan and cetuximab given every 2 weeks as second-line therapy for advanced colorectal cancer. [electronic resource] by
- Carneiro, Benedito A
- Ramanathan, Ramesh K
- Fakih, Marwan G
- Krishnamurthi, Smitha S
- Lembersky, Barry C
- Stoller, Ronald G
- Lancaster, Stewart L
- Pinkerton, Richard A
- Crandall, Theodore L
- Schmotzer, Amy R
- Potter, Douglas M
- Bahary, Nathan
Producer: 20120605
In:
Clinical colorectal cancer vol. 11
Availability: No items available.
|
|
5566.
|
Estimating preclinical efficacy targets utilizing cetuximab efficacy in KRAS mutant and wild-type colorectal cancer models. [electronic resource] by
- Prewett, Marie
- Bassi, Rajiv
- Paz, Keren
- Amatulli, Michael
- Deevi, Dhanvanthri
- Li, Huiling
- Wang, Su
- Witte, Larry
- Samakoglu, Selda
- Tonra, James R
Producer: 20111019
In:
Anticancer research vol. 31
Availability: No items available.
|
|
5567.
|
Cetuximab plus cisplatin, irinotecan, and thoracic radiotherapy as definitive treatment for locally advanced, unresectable esophageal cancer: a phase-II study of the SWOG (S0414). [electronic resource] by
- Tomblyn, Michael B
- Goldman, Bryan H
- Thomas, Charles R
- Benedetti, Jacqueline K
- Lenz, Heinz-Josef
- Mehta, Vivek
- Beeker, Thaddeus
- Gold, Philip J
- Abbruzzese, James L
- Blanke, Charles D
Producer: 20121018
In:
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer vol. 7
Availability: No items available.
|
|
5568.
|
Phase II study of maintenance sunitinib following irinotecan and carboplatin as first-line treatment for patients with extensive-stage small-cell lung cancer. [electronic resource] by
- Spigel, David R
- Greco, F Anthony
- Rubin, Mark S
- Shipley, Dianna
- Thompson, Dana S
- Lubiner, Eric T
- Eakle, Janice F
- Quinn, Raven
- Burris, Howard A
- Hainsworth, John D
Producer: 20121107
In:
Lung cancer (Amsterdam, Netherlands) vol. 77
Availability: No items available.
|
|
5569.
|
|
|
5570.
|
The role of HER-3 expression in the prediction of clinical outcome for advanced colorectal cancer patients receiving irinotecan and cetuximab. [electronic resource] by
- Scartozzi, Mario
- Mandolesi, Alessandra
- Giampieri, Riccardo
- Bittoni, Alessandro
- Pierantoni, Chiara
- Zaniboni, Alberto
- Galizia, Eva
- Giustini, Lucio
- Silva, Rosa Rita
- Bisonni, Renato
- Berardi, Rossana
- Biscotti, Tommasina
- Biagetti, Simona
- Bearzi, Italo
- Cascinu, Stefano
Producer: 20110628
In:
The oncologist vol. 16
Availability: No items available.
|
|
5571.
|
|
|
5572.
|
Randomized phase II trial of first-line treatment with tailored irinotecan and S-1 therapy versus S-1 monotherapy for advanced or recurrent gastric carcinoma (JFMC31-0301). [electronic resource] by
- Komatsu, Yoshito
- Takahashi, Yutaka
- Kimura, Yutaka
- Oda, Hisashi
- Tajima, Yusuke
- Tamura, Shigeyuki
- Sakurai, Jo
- Wakasugi, Takehiro
- Tatebe, Shigeru
- Takahashi, Masahiro
- Sakata, Yuh
- Kitajima, Masaki
- Sakamoto, Junichi
- Saji, Shigetoyo
Producer: 20110823
In:
Anti-cancer drugs vol. 22
Availability: No items available.
|
|
5573.
|
Phosphorylated AKT and MAPK expression in primary tumours and in corresponding metastases and clinical outcome in colorectal cancer patients receiving irinotecan-cetuximab. [electronic resource] by
- Scartozzi, Mario
- Giampieri, Riccardo
- Maccaroni, Elena
- Mandolesi, Alessandra
- Biagetti, Simona
- Alfonsi, Simona
- Giustini, Lucio
- Loretelli, Cristian
- Faloppi, Luca
- Bittoni, Alessandro
- Bianconi, Maristella
- Del Prete, Michela
- Bearzi, Italo
- Cascinu, Stefano
Producer: 20130219
In:
Journal of translational medicine vol. 10
Availability: No items available.
|
|
5574.
|
Gender influences the class III and V β-tubulin ability to predict poor outcome in colorectal cancer. [electronic resource] by
- Mariani, Marisa
- Zannoni, Gian Franco
- Sioletic, Stefano
- Sieber, Steven
- Martino, Candice
- Martinelli, Enrica
- Coco, Claudio
- Scambia, Giovanni
- Shahabi, Shohreh
- Ferlini, Cristiano
Producer: 20121105
In:
Clinical cancer research : an official journal of the American Association for Cancer Research vol. 18
Availability: No items available.
|
|
5575.
|
|
|
5576.
|
|
|
5577.
|
A phase II trial of trastuzumab combined with irinotecan in patients with advanced HER2-positive chemo-refractory gastric cancer: Osaka Gastrointestinal Cancer Chemotherapy Study Group OGSG1203 (HERBIS-5). [electronic resource] by
- Sakai, Daisuke
- Satoh, Taroh
- Kurokawa, Yukinori
- Kudo, Toshihiro
- Nishikawa, Kazuhiro
- Oka, Yoshio
- Tsujinaka, Toshimasa
- Shimokawa, Toshio
- Doki, Yuichiro
- Furukawa, Hiroshi
Producer: 20131104
In:
Japanese journal of clinical oncology vol. 43
Availability: No items available.
|
|
5578.
|
Prospective study of EGFR intron 1 (CA)n repeats variants as predictors of benefit from cetuximab and irinotecan in chemo-refractory metastatic colorectal cancer (mCRC) patients. [electronic resource] by
- Loupakis, F
- Antoniotti, C
- Cremolini, C
- Zhang, W
- Yang, D
- Wakatsuki, T
- Bohanes, P
- Schirripa, M
- Salvatore, L
- Masi, G
- Ricci, V
- Graziano, F
- Ruzzo, A
- Benhaim, L
- Marmorino, F
- Ning, Y
- El-Khoueiry, R
- Falcone, A
- Lenz, H-J
Producer: 20151008
In:
The pharmacogenomics journal vol. 14
Availability: No items available.
|
|
5579.
|
|
|
5580.
|
Clinicopathological outcomes of preoperative chemoradiotherapy using S-1 plus Irinotecan for T4 lower rectal cancer. [electronic resource] by
- Beppu, Naohito
- Yoshie, Hidenori
- Kimura, Fumihiko
- Aihara, Tsukasa
- Doi, Hiroshi
- Kamikonya, Norihiko
- Matsubara, Nagahide
- Tomita, Naohiro
- Yanagi, Hidenori
- Yamanaka, Naoki
Producer: 20170308
In:
Surgery today vol. 46
Availability: No items available.
|